Showing results (51-60 of 190) with videos related to
Sort By:
Pageof 19
Cancer Science|May 13, 2009
Very low prevalence of XPD K751Q polymorphism and its association with XPD expression and outcomes of FOLFOX-4 treatment in Asian patients with colorectal carcinomaJiun-I Lai, Cheng-Hwai Tzeng, Po-Min Chen, et al.Annals of Hematology|October 13, 2006
Higher fungal infection rate in elderly patients (more than 80 years old) suffering from diffuse large B cell lymphoma and treated with rituximab plus CHOPPeng-Chan Lin, Liang-Tsai Hsiao, Say-Bee Poh, et al.Annals of Hematology|August 8, 2012
Large pericardial effusion as a life-threatening complication after hematopoietic stem cell transplantation-association with chronic GVHD in late-onset adult patientsYao-Chung Liu, Jyh-Pyng Gau, Ying-Chung Hong, et al.Cancer Investigation|May 29, 2007
Randomized Phase II trial of thalidomide alone versus thalidomide plus interferon alpha in patients with refractory multiple myelomaTzeon-Jye Chiou, Teng-Hsu Wang, Tsu-Yi Chao, et al.Cancer Science|November 20, 2009
Influence of GSTP1 I105V polymorphism on cumulative neuropathy and outcome of FOLFOX-4 treatment in Asian patients with colorectal carcinomaYen-Chung Chen, Cheng-Hwai Tzeng, Po-Min Chen, et al.British Journal of Haematology|May 25, 2002
Stevens-Johnson syndrome after treatment with STI571: a case reportLiang-Tsai Hsiao, Hung-Ming Chung, Jen-Tsun Lin, et al.Cancer|September 16, 2003
Non-Hodgkin lymphoma in elderly patients: experience at Taipei Veterans General HospitalLi-Yuan Bai, Muh-Hwa Yang, Tzeon-Jye Chiou, et al.Hematological Oncology|August 12, 2014
Pharmacokinetic profile and first preliminary clinical evaluation of bendamustine in Taiwanese patients with heavily pretreated indolent B-cell non-Hodgkin lymphoma and mantle cell lymphomaLiang-Tsai Hsiao, Hwei-Fang Tien, Ching-Yuan Kuo, et al.Cancer Science|December 11, 2008
ERCC1 codon 118 C→T polymorphism associated with ERCC1 expression and outcome of FOLFOX-4 treatment in Asian patients with metastatic colorectal carcinomaPeter Mu-Hsin Chang, Cheng-Hwai Tzeng, Po-Min Chen, et al.Anti-Cancer Drugs|May 31, 2008
Oral bioavailability of a novel paclitaxel formulation (Genetaxyl) administered with cyclosporin A in cancer patientsZyting Chu, Jen-Shi Chen, Chi-Ting Liau, et al.Pageof 19